ARDM INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Aradigm Corporation Investors

BENSALEM, Pa.--()--Law Offices of Howard G. Smith announces an investigation on behalf of Aradigm Corporation (“Aradigm” or the “Company”) (NASDAQ: ARDM) investors concerning the Company and its officers’ possible violations of federal securities laws.

“there were too many uncertainties with regard to duration of treatment, frequency of administration and endpoints to allow for reliance on a single Phase 3 trial”

On January 9, 2018, the U.S. Food and Drug Administration (“FDA”) released its briefing document for the January 11, 2018 meeting of the Antimicrobial Drugs Advisory Committee to discuss the New Drug Application for Linhaliq™ for the proposed indication of treatment of non-cystic fibrosis bronchiectasis (“NCFB”). The FDA stated that “there were too many uncertainties with regard to duration of treatment, frequency of administration and endpoints to allow for reliance on a single Phase 3 trial” of the drug, and that the FDA recommended Aradigm conduct “two independent trials” to provide evidence supporting the drug’s “overall demonstration of efficacy and safety.”

On this news, shares of Aradigm fell significantly, thereby injuring investors.

If you purchased Aradigm securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Recent Stories

RSS feed for Law Offices of Howard G. Smith

Release Summary

ARDM INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Aradigm Corporation Investors

Law Offices of Howard G. Smith